TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30768860

Group type: EXPERIMENTAL
Intervention: Filgotinib maleate tablets (100 mg and 200 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Filgotinib maleate tablets with food (high-fat meal)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Filgotinib maleate tablets with omeprazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Filgotinib maleate tablets with famotidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference tablet (filgotinib hydrochloride)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Food intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acid-reducing agents (ARAs)
Number of subjects: 0
Study: 28712478

Group type: EXPERIMENTAL
Intervention: Topical anesthesia (EMLA cream)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Two-point acupressure
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (routine prevenipuncture care)
Number of subjects: 120
Study: 26401593

Group type: EXPERIMENTAL
Intervention: Lifestyle
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: OCP
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Combined
Number of subjects: 149
Study: 22258311

Group type: EXPERIMENTAL
Intervention: Single TightRope™ technique (STR)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Double TightRope™ technique (DTR)
Number of subjects: 29
Study: 25665209

Group type: EXPERIMENTAL
Intervention: Modified Fox test protocol (MFT)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Direct estimation of VO2(max) via incremental bicycle exercise and expired gas analysis
Number of subjects: 111
Study: 19534799

Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg
Number of subjects: 1493

Group type: EXPERIMENTAL
Intervention: Pregabalin 450 mg
Number of subjects: 1493

Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg
Number of subjects: 1493

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1493
Study: 22632587

Group type: EXPERIMENTAL
Intervention: Segmental stabilization exercises (SSEs)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Stretching of trunk and hamstrings muscles
Number of subjects: 30
Study: 15954874

Group type: EXPERIMENTAL
Intervention: Vaginal cleansing with chlorhexidine
Number of subjects: 486

Group type: COMPARATOR
Intervention: No vaginal cleansing
Number of subjects: 486
Study: 12798785

Group type: EXPERIMENTAL
Intervention: 200 mg NaCl
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 400 mg NaCl
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 600 mg NaCl
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (empty capsule)
Number of subjects: 80
Study: 9718051

Group type: EXPERIMENTAL
Intervention: 0.625 mg of conjugated equine estrogens plus 2.5 mg of medroxyprogesterone acetate (hormone group)
Number of subjects: 2763

Group type: COMPARATOR
Intervention: Placebo (placebo group)
Number of subjects: 2763
Study: 8124968

Group type: EXPERIMENTAL
Intervention: Pressure-limited ventilation
Number of subjects: 27

Group type: COMPARATOR
Intervention: Volume-controlled ventilation
Number of subjects: 27
Study: 2530634

Group type: EXPERIMENTAL
Intervention: 25 gauge needle
Number of subjects: 274

Group type: COMPARATOR
Intervention: 23 gauge needle
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Both 23 gauge and 25 gauge needles
Number of subjects: 274
Study: 331504

Group type: EXPERIMENTAL
Intervention: Tolmetin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study: 29549893

Group type: EXPERIMENTAL
Intervention: Sacroiliac joint mobilization
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Self-mobilization
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 20
Study: 27510498

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coordination task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 0
Study: 24441734

Group type: EXPERIMENTAL
Intervention: Microfracture technique (MF)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Osteochondral autologous transplantation (OAT) mosaicplasty
Number of subjects: 25
Study: 23945285

Group type: EXPERIMENTAL
Intervention: Seven favorable environmental factors present
Number of subjects: 50685

Group type: EXPERIMENTAL
Intervention: Four favorable environmental factors present
Number of subjects: 50685

Group type: COMPARATOR
Intervention: No favorable environmental factors
Number of subjects: 50685
Study: 20739426

Group type: EXPERIMENTAL
Intervention: VA/BC supplementation
Number of subjects: 594

Group type: COMPARATOR
Intervention: No VA/BC supplementation (Control)
Number of subjects: 594

Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation
Number of subjects: 594

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 594
Study: 18278679

Group type: EXPERIMENTAL
Intervention: Minimized extracorporeal circulation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard extracorporeal circulation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 15747808

Group type: EXPERIMENTAL
Intervention: Rapid maxillary expansion (RME) in early-treated group (group I T)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Rapid maxillary expansion (RME) in late-treated group (group II T)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (early-control group I C)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (late-control group II C)
Number of subjects: 29
Study: 12703668

Group type: EXPERIMENTAL
Intervention: Magnesium (Mg) 732 mg/day
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 10337546

Group type: EXPERIMENTAL
Intervention: Left atrioventricular plane displacement
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Log‐1 Edt
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Fractional shortening
Number of subjects: 54
Study: 7473964

Group type: EXPERIMENTAL
Intervention: Injection into the antecubital fossa
Number of subjects: 100

Group type: COMPARATOR
Intervention: Injection into the dorsum of the hand
Number of subjects: 100
Study: 2029037

Group type: EXPERIMENTAL
Intervention: Filtered water (reverse-osmosis)
Number of subjects: 606

Group type: COMPARATOR
Intervention: Tapwater without a filter
Number of subjects: 606
Study: 7447362

Group type: EXPERIMENTAL
Intervention: Benzyl penicillin
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Clindamycin + gentamicin
Number of subjects: 147

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 147
Study: 31633580

Group type: EXPERIMENTAL
Intervention: Visual feedback training with visual targets on gradual weight shifting
Number of subjects: 21

Group type: COMPARATOR
Intervention: Visual feedback training on gradual weight shifting
Number of subjects: 21
Study: 29402157

Group type: EXPERIMENTAL
Intervention: Ligation of internal iliac arteries (IIA)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Temporary occlusion of common iliac artery (CIA)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Combined compression hemostasis
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: All surgical techniques
Number of subjects: 54
Study: 28464270

Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 25868737

Group type: EXPERIMENTAL
Intervention: Minimal epididymal cystectomy with scrotoscope (MECS)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Traditional open epididymal cystectomy (OEC)
Number of subjects: 48
Study: 23962993

Group type: EXPERIMENTAL
Intervention: Riluzole combined with surgical decompression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical decompression
Number of subjects: 0
Study: 21245205

Group type: EXPERIMENTAL
Intervention: Community-based ambulation training (1 hour, once a day, three times a week for 4 weeks)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Routine physical therapy
Number of subjects: 25
Study: 19234720

Group type: EXPERIMENTAL
Intervention: Detection of antibodies against BCL-2 in patients' sera
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Anti-BCL-2 antibodies
Number of subjects: 95
Study: 18184536

Group type: EXPERIMENTAL
Intervention: Meracilina/Pen‐Ve‐Oral 500,000 UI
Number of subjects: 26
Study: 15369506

Group type: EXPERIMENTAL
Intervention: REMUNE therapy every 12 weeks for 132 weeks
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: REMUNE therapy
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: REMUNE monotherapy or REMUNE plus antiretrovirals (ARTs)
Number of subjects: 223
Study: 10875859

Group type: EXPERIMENTAL
Intervention: 75 microg desogestrel
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 150 microg desogestrel
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 300 microg desogestrel
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Testosterone (300 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no desogestrel)
Number of subjects: 30
Study: 9104523

Group type: EXPERIMENTAL
Intervention: 0.2 mg.kg-1 propofol
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (intralipid 10%)
Number of subjects: 70
Study: 8251277

Group type: EXPERIMENTAL
Intervention: PCA with background infusion of morphine 20 micrograms kg‐1 h‐1
Number of subjects: 40

Group type: COMPARATOR
Intervention: PCA only (bolus dose 20 micrograms kg‐1 with a lockout interval of 5 min)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PCA with background infusion of morphine
Number of subjects: 40
Study: 3697654

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Chemotherapy (CMF)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Radiotherapy followed by chemotherapy
Number of subjects: 322

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 322
Study: 28425562

Group type: EXPERIMENTAL
Intervention: Web-based intervention for relationship distress
Number of subjects: 300

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 300
Study: 26439829

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 28
Study: 24903985

Group type: EXPERIMENTAL
Intervention: Electronic decision support tools for intensified secondary prevention for 12 months
Number of subjects: 11391

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 11391
Study: 23100609

Group type: EXPERIMENTAL
Intervention: Parental report of adherence
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Parental report of reasons for non-adherence
Number of subjects: 132
Study: 20980643

Group type: EXPERIMENTAL
Intervention: Red meat intervention (n = 90)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Fortified manufactured toddler milk drink (FTMD) intervention (n = 45)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Nonfortified milk placebo (n = 90)
Number of subjects: 225
Study: 19021989

Group type: EXPERIMENTAL
Intervention: Mononuclear bone marrow cell (MN‐BMC) transplantation, mean number of 6.59 x 10(8) +/- 5.12 x 10(8) MN‐BMC injected during CABG
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (CABG alone)
Number of subjects: 36
Study: 16385751

Group type: EXPERIMENTAL
Intervention: After-school physical activity program
Number of subjects: 278
Study: 12420619

Group type: EXPERIMENTAL
Intervention: Algosteril (calcium alginate) dressing
Number of subjects: 67

Group type: COMPARATOR
Intervention: Jelonet (paraffin gauze) dressing
Number of subjects: 67
Study: 9442170

Group type: EXPERIMENTAL
Intervention: 17 beta‐oestradiol eye drops (n = 42, group 1)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Tear substitute (n = 42, group 2)
Number of subjects: 84
Study: 8584072

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASS) at dosages of > or = 975 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASS) at dosages of about 300 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASS) at dosages of < or = 100 mg per day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2234995

Group type: EXPERIMENTAL
Intervention: EMLA (topical anesthetic)
Number of subjects: 28
Study: 346607

Group type: EXPERIMENTAL
Intervention: Progressive Relaxation Training (PRT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Meditation Training (MT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Quiet Rest (QR)
Number of subjects: 30
Study: 30395000

Group type: EXPERIMENTAL
Intervention: ED trigger tool
Number of subjects: 2594
Study: 31493749

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Spirit only MI (SOMI)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Non-therapy control
Number of subjects: 89
Study: 30006024

Group type: EXPERIMENTAL
Intervention: Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced treatment as usual (TAU)
Number of subjects: 0
Study: 26639204

Group type: EXPERIMENTAL
Intervention: Prasugrel plus bivalirudin
Number of subjects: 71

Group type: COMPARATOR
Intervention: Clopidogrel plus heparin
Number of subjects: 71
Study: 24558093

Group type: EXPERIMENTAL
Intervention: PBMC nascent proteome
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PBMC total proteome
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matched controls (not specified how many)
Number of subjects: 0
Study: 22246331

Group type: EXPERIMENTAL
Intervention: Tobramycin 0.3%
Number of subjects: 42

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 42
Study: 19875761

Group type: EXPERIMENTAL
Intervention: Anti‐CD20 monoclonal antibody therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy alone (anthracycline‐based)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FOXP3 cells and LAMs
Number of subjects: 0
Study: 17376250

Group type: EXPERIMENTAL
Intervention: Laryngeal tube
Number of subjects: 132

Group type: COMPARATOR
Intervention: Laryngeal mask
Number of subjects: 132
Study: 15797671

Group type: EXPERIMENTAL
Intervention: Inulin-fortified beverages (13 g/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isocaloric standard modified starch-thickened beverages
Number of subjects: 0
Study: 12019107

Group type: EXPERIMENTAL
Intervention: Zidovudine (AZT) at 250 to 300 mg twice daily, 3TC at 150 mg twice daily, and indinavir at 800 mg every 8 h
Number of subjects: 170

Group type: COMPARATOR
Intervention: Stavudine (d4T) at 40 mg twice daily, 3TC at 150 mg twice daily, and indinavir at 800 mg every 8 h
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Zidovudine (AZT)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Stavudine (d4T)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Both AZT and d4T arms
Number of subjects: 170
Study: 9824171

Group type: EXPERIMENTAL
Intervention: Short-term anxiety-provoking psychotherapy (STAPP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nondirective therapy with common factors of psychotherapy
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both treatments (STAPP and nondirective therapy)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Therapeutic alliance
Number of subjects: 20
Study: 8120917

Group type: EXPERIMENTAL
Intervention: GnRHA-based contraceptive regimen (7.5 mg leuprolide acetate depot every 28 days, 0.625 mg conjugated estrogen for 6 days each week, 10 mg medroxyprogesterone acetate for 13 days every fourth cycle)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: GnRHA-based contraceptive regimen
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 21
Study: 2683658

Group type: EXPERIMENTAL
Intervention: 0.4 ml/kg of iohexol
Number of subjects: 59

Group type: COMPARATOR
Intervention: 0.8 ml/kg of iohexol
Number of subjects: 59
Study: 1098887

Group type: EXPERIMENTAL
Intervention: Slow-release aminophylline (350 mg, released over eight hours)
Number of subjects: 26
Study: 295486

Group type: EXPERIMENTAL
Intervention: 0.1% NaF + 2% chlorhexidine
Number of subjects: 91

Group type: COMPARATOR
Intervention: 2% chlorhexidine
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 0.1% NaF
Number of subjects: 91
Study: 31752975

Group type: EXPERIMENTAL
Intervention: Interactive educational intervention (video fragments, discussion, quizzes with tailored feedback, exercise filling out a registration form) during two 50-min lessons.
Number of subjects: 1170

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 1170
Study: 30096107

Group type: EXPERIMENTAL
Intervention: 1,550-nm Er:Glass fractional laser treatment
Number of subjects: 23
Study: 27637770

Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation (FES) cycling program, five times a week over a 4-week period, in addition to usual care.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care alone.
Number of subjects: 40
Study: 23829785

Group type: EXPERIMENTAL
Intervention: Vitamin D-fortified doogh (DD; containing 150 mg of calcium + 500 IU vitamin D per 250 mL)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Calcium-vitamin D-fortified doogh (CDD; containing 250 mg of calcium + 500 IU vitamin D per 250 mL)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Plain doogh (PD; containing 150 mg per 250 mL of calcium and no detectable vitamin D)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Calcium-vitamin D-fortified doogh (CDD)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Vitamin D-fortified doogh (DD)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Plain doogh (PD)
Number of subjects: 90
Study: 22563020

Group type: EXPERIMENTAL
Intervention: PEG‐IFN/RBV
Number of subjects: 329

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 329
Study: 19317579

Group type: EXPERIMENTAL
Intervention: Endovascular Aneurysm Repair (EVAR) with Zenith stent-graft (CAESAR trial)
Number of subjects: 1765

Group type: EXPERIMENTAL
Intervention: Endovascular Aneurysm Repair (EVAR) with AneuRx or Talent stent-grafts (PIVOTAL trial)
Number of subjects: 1765

Group type: COMPARATOR
Intervention: Surveillance (CAESAR trial)
Number of subjects: 1765

Group type: COMPARATOR
Intervention: Surveillance (PIVOTAL trial)
Number of subjects: 1765
Study: 17161655

Group type: EXPERIMENTAL
Intervention: Second-generation fecal DNA assay (version 2) with improved DNA stabilization/isolation techniques and new promoter methylation marker.
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Combination of vimentin methylation plus DNA integrity assay (DIA).
Number of subjects: 162

Group type: COMPARATOR
Intervention: Prototype fecal DNA assay (version 1).
Number of subjects: 162
Study: 15732871

Group type: EXPERIMENTAL
Intervention: Platelet concentrate grafts (PCG)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Subepithelial connective tissue grafts (SCTG)
Number of subjects: 15
Study: 12379887

Group type: EXPERIMENTAL
Intervention: G-CSF treatment started on day 6 post transplant
Number of subjects: 42

Group type: COMPARATOR
Intervention: G-CSF treatment started on day 9 post transplant
Number of subjects: 42
Study: 9805219

Group type: EXPERIMENTAL
Intervention: Low-saturated fat high-carbohydrate diet (22%, 6%, and 59% energy from total, saturated, and carbohydrate, respectively)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Low-saturated fat high-carbohydrate diet
Number of subjects: 38

Group type: COMPARATOR
Intervention: Traditional Western diet (36%, 18%, and 43% energy from total, saturated, and carbohydrate, respectively)
Number of subjects: 38
Study: 7653803

Group type: EXPERIMENTAL
Intervention: Propofol infused to maintain EEG burst suppression
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sufentanil and vecuronium (control group)
Number of subjects: 30
Study: 2757327

Group type: EXPERIMENTAL
Intervention: Vaginal suppositories of PDRN (5g preparation)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vaginal suppositories of PDRN (10g preparation)
Number of subjects: 20
Study: 3963

Group type: EXPERIMENTAL
Intervention: Oxprenolol (Trasicor)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Oxprenolol (Trasicor) + cyclopenthiazide
Number of subjects: 11

Group type: COMPARATOR
Intervention: Cyclopenthiazide
Number of subjects: 11
Study: 31972601

Group type: EXPERIMENTAL
Intervention: Bolus human albumin 5%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bolus ringer acetate 250 ml
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Other haemodynamic variables
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fluid-related complications
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Length of stay (LOS) in ICU and hospital
Number of subjects: 60
Study: 29331656

Group type: EXPERIMENTAL
Intervention: Optimal turning practices influenced by real-time data from a wearable patient sensor (treatment group, n=659)
Number of subjects: 1312

Group type: COMPARATOR
Intervention: Traditional turn reminders and standard practices (control group, n=653)
Number of subjects: 1312
Study: 27481621

Group type: EXPERIMENTAL
Intervention: Restrictive threshold (transfuse if haemoglobin <7.5 g/dL)
Number of subjects: 2003

Group type: COMPARATOR
Intervention: Liberal threshold (transfuse if haemoglobin <9 g/dL)
Number of subjects: 2003
Study: 24246541

Group type: EXPERIMENTAL
Intervention: Home-based and supervised exercise programs (intermittent walking to near maximal claudication pain for 3 months)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (diabetic women)
Number of subjects: 80
Study: 22052867

Group type: EXPERIMENTAL
Intervention: 1.5 g/day each of d‐pantothenic acid and l‐cysteine (CP)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo control (glucose polymer; CON)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both CP and CON
Number of subjects: 8
Study: 20394255

Group type: EXPERIMENTAL
Intervention: Granisetron 1 mg and dexamethasone 8 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ondansetron 4 mg and dexamethasone 8 mg
Number of subjects: 100
Study: 18514877

Group type: EXPERIMENTAL
Intervention: Electromagnetic (EM) navigation system
Number of subjects: 46

Group type: COMPARATOR
Intervention: Infrared (IR) navigation system
Number of subjects: 46
Study: 16425830

Group type: EXPERIMENTAL
Intervention: Radial basis function artificial neural networks (RBF ANN) for control of neural prosthesis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Functional electrical therapy (FET)
Number of subjects: 0